News

Treatment options are limited for those with sudden liver failure and the condition has a death rate as high as 50%.
The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...
The company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...
The new study will attach the pig liver to up to 20 patients in a bid to give their own livers time to regenerate. View on euronews ...